指南与共识腹部技术与安全US

超声肝脏影像报告和数据系统在LI-RADS算法中的作用

Role of US LI-RADS in the LI-RADS Algorithm.
PubMed 文献 · Radiographics · 2019-01-01

美国放射学会2017年发布的超声LI-RADS为肝细胞癌高危人群的筛查或监测超声提供标准化术语、技术建议和报告框架。筛查或监测研究需赋予US类别(US-1阴性、US-2亚阈值、US-3阳性)以决定随访,并赋予可视化评分(A、B、C)以传达检查的预期敏感度但不影响管理。

要点

  • 筛查或监测对象为有肝细胞癌风险但无已知或疑似癌症者,包括任何病因肝硬化和无肝硬化的慢性乙型肝炎病毒感染者亚组。
  • US-3阳性定义为发现≥10 mm的观察对象或静脉新发血栓,推荐进行诊断性对比增强影像检查。
  • 可视化评分A、B、C分别表示无或轻微、中度、严重限制,仅传达检查预期敏感度,不影响管理。

核心结论

  • US LI-RADS为肝细胞癌高危人群的筛查或监测超声提供标准化术语、技术建议和报告框架,通过US类别决定随访、可视化评分传达检查预期敏感度但不影响管理。

研究设计与样本

  • 美国放射学会(ACR)于2017年发布的LI-RADS算法之一,为超声检查提供标准化术语、技术建议和报告框架。

诊断标准与关键数值

  • US-1阴性:无肝细胞癌证据的检查。
  • US-2亚阈值:发现小于10 mm且不能明确为良性的观察对象。
  • US-3阳性:发现大于或等于10 mm的观察对象或静脉新发血栓,推荐进行诊断性对比增强影像检查。
  • 可视化评分A表示无或轻微限制,B表示中度限制,C表示严重限制。

临床应用与阅片要点

  • 对肝细胞癌高危人群的筛查或监测超声,应赋予US类别以决定随访。
  • 应赋予可视化评分以传达检查的预期敏感度,该评分不影响管理。
  • 发现大于或等于10 mm的观察对象或静脉新发血栓时归为US-3阳性,推荐进行诊断性对比增强影像检查。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The US Liver Imaging Reporting and Data System (LI-RADS) was released in 2017 and is the newest of the four American College of Radiology (ACR) LI-RADS algorithms. US LI-RADS provides standardized terminology, technical recommendations, and a reporting framework for US examinations performed for screening or surveillance in patients at risk for developing hepatocellular carcinoma (HCC). The appropriate patient population for screening and surveillance includes individuals who are at risk for developing HCC but do not have known or suspected cancer. This includes patients with cirrhosis from any cause and subsets of patients with chronic hepatitis B virus infection in the absence of cirrhosis. In an HCC screening or surveillance study, US LI-RADS recommends assigning two scores that apply to the entire study: the US category, which determines follow-up, and a visualization score, which communicates the expected level of sensitivity of the examination but does not affect management. Three US categories are possible: US-1 negative, a study with no evidence of HCC; US-2 subthreshold, a study in which an observation less than 10 mm is depicted that is not definitely benign; and US-3 positive, a study in which an observation greater than or equal to 10 mm or a new thrombus in vein is identified, for which diagnostic contrast material-enhanced imaging is recommended. Three visualization scores are possible: A (no or minimal limitations), B (moderate limitations), and C (severe limitations). ©RSNA, 2019.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Rodgers SK, Fetzer DT, Gabriel H, et al. Role of US LI-RADS in the LI-RADS Algorithm. Radiographics. 2019. PMID: 31059393. doi:10.1148/rg.2019180158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。